ID

27824

Descripción

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study; ODM derived from: https://clinicaltrials.gov/show/NCT00645736

Link

https://clinicaltrials.gov/show/NCT00645736

Palabras clave

Versiones (1)
  1. 30/11/17 30/11/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

30 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Hepatitis B NCT00645736

Inglés

Eligibility Chronic Hepatitis B NCT00645736

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 18 years and over
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
provided informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
diagnosis of chronic hepatitis b (hbsag documented for at least 6 months)
Descripción

Hepatitis B, Chronic | Hepatitis B Surface Antigens Documented

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0524909
UMLS CUI [2,1]
C0019168
UMLS CUI [2,2]
C1301725
currently prescribed antihepadnaviral therapy (including, but not limited to: lamivudine, adefovir, entecavir, tenofovir or telbivudine) for chronic hepatitis b management
Descripción

Therapeutic procedure Against Hepadnavirus prescribed | Lamivudine | adefovir | entecavir | Tenofovir | telbivudine | Chronic Hepatitis B Management

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0019132
UMLS CUI [1,4]
C0278329
UMLS CUI [2]
C0209738
UMLS CUI [3]
C0050175
UMLS CUI [4]
C0971023
UMLS CUI [5]
C0384228
UMLS CUI [6]
C1453933
UMLS CUI [7,1]
C0524909
UMLS CUI [7,2]
C0376636
been taking current antihepadnaviral therapy for at least 6 months prior to recruitment
Descripción

Therapeutic procedure Against Hepadnavirus

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0019132
negative tests for hiv ab, hepatitis c ab and hepatitis d ab within the previous 2 years
Descripción

HIV antibody negative | Hepatitis C antibody test negative | Hepatitis D antibody negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1142096
UMLS CUI [2]
C1277806
UMLS CUI [3]
C1167805
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected co-infection with hiv, hepatitis c or hepatitis d
Descripción

HIV coinfection | HCV coinfection | HDV Coinfection | HIV coinfection Suspected | HCV coinfection Suspected | HDV Coinfection Suspected

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C1698259
UMLS CUI [3,1]
C0011220
UMLS CUI [3,2]
C0275524
UMLS CUI [4,1]
C4062778
UMLS CUI [4,2]
C0750491
UMLS CUI [5,1]
C1698259
UMLS CUI [5,2]
C0750491
UMLS CUI [6,1]
C0011220
UMLS CUI [6,2]
C0275524
UMLS CUI [6,3]
C0750491
concomitant immunosuppression / immunomodulatory therapies
Descripción

Therapeutic immunosuppression | Immunomodulation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C1963758
diagnosis of hepatocellular carcinoma where anticipated life expectancy is less than 6 months
Descripción

Liver carcinoma | Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2239176
UMLS CUI [2]
C0023671
current participation in an interventional, blinded, pharmaceutical industry-sponsored clinical trial
Descripción

Study Subject Participation Status | Interventional Study | Blinded Clinical Study | Pharmaceutical Industry Clinical Study Sponsor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C3274035
UMLS CUI [3]
C2347038
UMLS CUI [4,1]
C0013185
UMLS CUI [4,2]
C2347796
current child pugh class c classification (current child pugh score > 9)
Descripción

Child-Pugh Clinical Classification | Child-Pugh - Total Score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4050412
UMLS CUI [2]
C4055253
other known or suspected cause of chronic liver disease
Descripción

Cause Chronic liver disease | Cause Suspected Chronic liver disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0341439
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0341439
any other reason that, in the investigator's opinion, participation in the study would not be in the participant's best interest.
Descripción

Reason Study Subject Participation Status Unfavorable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C3640815
Volver a la parte superior de la página

Similar models

Eligibility Chronic Hepatitis B NCT00645736

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
aged 18 years and over
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
provided informed consent
boolean
C0021430 (UMLS CUI [1])
Hepatitis B, Chronic | Hepatitis B Surface Antigens Documented
Item
diagnosis of chronic hepatitis b (hbsag documented for at least 6 months)
boolean
C0524909 (UMLS CUI [1])
C0019168 (UMLS CUI [2,1])
C1301725 (UMLS CUI [2,2])
Therapeutic procedure Against Hepadnavirus prescribed | Lamivudine | adefovir | entecavir | Tenofovir | telbivudine | Chronic Hepatitis B Management
Item
currently prescribed antihepadnaviral therapy (including, but not limited to: lamivudine, adefovir, entecavir, tenofovir or telbivudine) for chronic hepatitis b management
boolean
C0087111 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0019132 (UMLS CUI [1,3])
C0278329 (UMLS CUI [1,4])
C0209738 (UMLS CUI [2])
C0050175 (UMLS CUI [3])
C0971023 (UMLS CUI [4])
C0384228 (UMLS CUI [5])
C1453933 (UMLS CUI [6])
C0524909 (UMLS CUI [7,1])
C0376636 (UMLS CUI [7,2])
Therapeutic procedure Against Hepadnavirus
Item
been taking current antihepadnaviral therapy for at least 6 months prior to recruitment
boolean
C0087111 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0019132 (UMLS CUI [1,3])
HIV antibody negative | Hepatitis C antibody test negative | Hepatitis D antibody negative
Item
negative tests for hiv ab, hepatitis c ab and hepatitis d ab within the previous 2 years
boolean
C1142096 (UMLS CUI [1])
C1277806 (UMLS CUI [2])
C1167805 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
HIV coinfection | HCV coinfection | HDV Coinfection | HIV coinfection Suspected | HCV coinfection Suspected | HDV Coinfection Suspected
Item
known or suspected co-infection with hiv, hepatitis c or hepatitis d
boolean
C4062778 (UMLS CUI [1])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C1698259 (UMLS CUI [5,1])
C0750491 (UMLS CUI [5,2])
C0011220 (UMLS CUI [6,1])
C0275524 (UMLS CUI [6,2])
C0750491 (UMLS CUI [6,3])
Therapeutic immunosuppression | Immunomodulation
Item
concomitant immunosuppression / immunomodulatory therapies
boolean
C0021079 (UMLS CUI [1])
C1963758 (UMLS CUI [2])
Liver carcinoma | Life Expectancy
Item
diagnosis of hepatocellular carcinoma where anticipated life expectancy is less than 6 months
boolean
C2239176 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Study Subject Participation Status | Interventional Study | Blinded Clinical Study | Pharmaceutical Industry Clinical Study Sponsor
Item
current participation in an interventional, blinded, pharmaceutical industry-sponsored clinical trial
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
C2347038 (UMLS CUI [3])
C0013185 (UMLS CUI [4,1])
C2347796 (UMLS CUI [4,2])
Child-Pugh Clinical Classification | Child-Pugh - Total Score
Item
current child pugh class c classification (current child pugh score > 9)
boolean
C4050412 (UMLS CUI [1])
C4055253 (UMLS CUI [2])
Cause Chronic liver disease | Cause Suspected Chronic liver disease
Item
other known or suspected cause of chronic liver disease
boolean
C0015127 (UMLS CUI [1,1])
C0341439 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0341439 (UMLS CUI [2,3])
Reason Study Subject Participation Status Unfavorable
Item
any other reason that, in the investigator's opinion, participation in the study would not be in the participant's best interest.
boolean
C0392360 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C3640815 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial